overview-v2-full
Black
White
Similar Risk
Other
None
None
None
overview-v2-mobile
Black
White
Similar Risk
Other
Black
White
Similar
Other
None
None
None
multiple-myeloma-full
6
1
4
4
6
R
ep
r
e
sen
t
ation in Clinical
T
rials
White
Black
Asian
N
ati
v
e American
White
Black
Asian
N
ati
v
e American
White
Black
Asian
N
ati
v
e American
N
e
w
C
as
e
s of
M
ultiple
M
y
eloma,
P
er 10
0,
000
P
eople
10%
6%
Not
r
epo
r
ted
7
6%
Dar
z
al
e
x
4
%
10%
<1%
8
4
%
Empliciti
3
%
3
3
%
Not
r
epo
r
ted
6
3
%
F
a
r
y
dak
2%
9
%
Not
r
epo
r
ted
8
5
%
Ninla
r
o
multiple-myeloma-mobile
6
1
4
4
6
R
ep
r
e
sen
t
ation in Clinical
T
rials
White
Black
Asian
N
ati
v
e American
White
Black
Asian
N
ati
v
e American
White
Black
Asian
N
ati
v
e American
White
Black
Asian
N
ati
v
e American
White
Black
Asian
N
ati
v
e American
N
e
w
C
as
e
s of
M
ultiple
M
y
eloma,
P
er 10
0,
000
P
eople
10%
6%
Not
r
epo
r
ted
7
6%
Dar
z
al
e
x
4
%
10%
<1%
8
4
%
Empliciti
3
%
3
3
%
Not
r
epo
r
ted
6
3
%
F
a
r
y
dak
2%
9
%
Not
r
epo
r
ted
8
5
%
Ninla
r
o
t
nsclc-full
2%
1
8
%
<1%
7
4
%
N
e
w
C
as
e
s of N
S
C
LC
,
P
er 10
0,
000
P
eople
Alunbrig:
R
ep
r
e
s
en
t
ation in Clinical
T
rials
Alecensa:
R
ep
r
e
sen
t
ation in Clinical
T
rials
5
4
63
35
36
Not
r
epo
r
ted
1%
3
1%
White
Black
Asian
N
ati
v
e American
6
7%
nsclc-mobile
N
e
w
C
as
e
s of N
S
C
LC
,
P
er 10
0,
000
P
eople
5
4
63
35
36
White
Black
Asian
N
ati
v
e American
White
Black
Asian
N
ati
v
e American
White
Black
Asian
N
ati
v
e American
2%
1
8
%
<1%
7
4
%
Alunbrig:
R
ep
r
e
sen
t
ation in Clinical
T
rials
Alecensa:
R
ep
r
e
sen
t
ation in Clinical
T
rials
Not
r
epo
r
ted
1%
3
1%
6
7%
prostate-full
106
1
7
8
5
9
5
5
White
Black
Asian
N
ati
v
e American
N
e
w
C
as
e
s of P
r
os
t
ate
C
ance
r
,
P
er 10
0,
000
P
eople
6%
12%
<1%
6
6%
Erl
e
ada:
R
ep
r
e
sen
t
ation in Clinical
T
rials
prostate-mobile
106
1
7
8
5
9
5
5
White
Black
Asian
N
ati
v
e American
White
Black
Asian
N
ati
v
e American
N
e
w
C
as
e
s of P
r
os
t
ate
C
ance
r
,
P
er 10
0,
000
P
eople
6%
12%
<1%
6
6%
Erl
e
ada:
R
ep
r
e
sen
t
ation in Clinical
T
rials
colorectal-full
N
e
w
C
as
e
s of Colo
r
ec
t
al
C
ance
r
,
P
er 10
0,
000
P
eople
L
onsu
r
f
:
R
ep
r
e
sen
t
ation in Clinical
T
rials
39
1%
3
5
%
Not
r
epo
r
ted
49
3
4
42
White
Black
Asian
N
ati
v
e American
5
8
%
colorectal-mobile
N
e
w
C
as
e
s of Colo
r
ec
t
al
C
ance
r
,
P
er 10
0,
000
P
eople
39
49
3
4
42
White
Black
Asian
N
ati
v
e American
White
Black
Asian
N
ati
v
e American
L
onsu
r
f
:
R
ep
r
e
sen
t
ation in Clinical
T
rials
1%
3
5
%
Not
r
epo
r
ted
5
8
%
Source:
U.S. Food and Drug Administration
;
National Cancer Institute
Credit:
Riley Wong/ProPublica